Post by Roche
4,453,202 followers
For us, leadership in blood cancer care is about a continuous commitment to the standard of care and carefully looking at where we go next. π While progress in lymphoma care continues, we know that treatment can be challenging, with a significant impact on patientsβ everyday lives. Through combination approaches, our focus remains on improving outcomes while helping to better support patients throughout their care. Hear from Steve Tuplin, Disease Area Head for Haematology at Roche, as he shares our long-term vision for lymphoma care so that patients can live longer, healthier lives. #RocheHematology #EHA2026 #lymphoma
Video Content